JCR Pharmaceuticals Co Ltd
TSE:4552
JCR Pharmaceuticals Co Ltd
EPS (Diluted)
JCR Pharmaceuticals Co Ltd
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
J
|
JCR Pharmaceuticals Co Ltd
TSE:4552
|
EPS (Diluted)
¥42
|
CAGR 3-Years
9%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-1%
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
EPS (Diluted)
¥112
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-5%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
EPS (Diluted)
¥96
|
CAGR 3-Years
39%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-5%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
EPS (Diluted)
¥253
|
CAGR 3-Years
-4%
|
CAGR 5-Years
12%
|
CAGR 10-Years
-1%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
EPS (Diluted)
¥197
|
CAGR 3-Years
15%
|
CAGR 5-Years
29%
|
CAGR 10-Years
8%
|
|
Astellas Pharma Inc
TSE:4503
|
EPS (Diluted)
¥20
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-7%
|
See Also
What is JCR Pharmaceuticals Co Ltd's EPS (Diluted)?
EPS (Diluted)
43
JPY
Based on the financial report for Dec 31, 2023, JCR Pharmaceuticals Co Ltd's EPS (Diluted) amounts to 43 JPY.
What is JCR Pharmaceuticals Co Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
-1%
Over the last year, the EPS (Diluted) growth was 5%. The average annual EPS (Diluted) growth rates for JCR Pharmaceuticals Co Ltd have been 9% over the past three years , -12% over the past five years , and -1% over the past ten years .